Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland.

Keitel, Kristina; Alcoba, Gabriel; Lacroix, Lacroix; Manzano, Sergio; Galetto-Lacour, Annick; Gervaix, Alain (2014). Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland. Swiss medical weekly, 144(w13925), w13925. EMH Media 10.4414/smw.2014.13925

[img] Text
smw_2014_13925.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (444kB) | Request a copy

QUESTIONS UNDER STUDY

Despite various efforts to estimate cost-effectiveness of pneumococcal conjugate vaccines, only scarce information on the cost burden of paediatric community acquired pneumonia (CAP) exists. The objective of this study was to prospectively calculate direct and indirect costs associated with treatment of CAP from a society perspective in children between 2 months and 16 years of age seeking care at a tertiary hospital in Geneva, Switzerland between December 2008 and May 2010.

METHODS

This cost of illness study population comprised children aged from 2 months to 16 years of age seeking care for CAP at the University Children's Hospital Geneva from January 2008 through May 2010 (a subset of patients taken from a larger multicentre prospective cohort). Hospital-associated costs for episodes of pneumonia were computed according to the REKOLE® system. Non-hospital costs were estimated by parental interviews at baseline and follow-up on day 14.

RESULTS

The overall cost for one episode of CAP was 11'258 CHF; 23'872 CHF for inpatient treatment and 1009 CHF for outpatient treatment. Severe pneumonia cases per World Health Organisation (WHO) definition used significantly more hospital resources than non-severe cases: 21'842 CHF versus 3'479 CHF (p <0.0001).

CONCLUSION

Childhood CAP results in a significant medical cost burden that may have been underestimated in previous cost-effectiveness analyses of pneumococcal vaccine strategies.

Item Type:

Journal Article (Original Article)

UniBE Contributor:

Keitel, Kristina

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1424-3997

Publisher:

EMH Media

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

25 Nov 2021 15:22

Last Modified:

05 Dec 2022 15:54

Publisher DOI:

10.4414/smw.2014.13925

PubMed ID:

24706389

BORIS DOI:

10.48350/160553

URI:

https://boris.unibe.ch/id/eprint/160553

Actions (login required)

Edit item Edit item
Provide Feedback